searchspell:

elnorm

corrected for zelnorm

Tegaserod is a 5-HT₄ agonist used for the management of constipation-predominant irritable bowel syndrome (IBS). It is currently marketed by Novartis under the trade names Zelnorm (in the US) or Zelmac (in other countries).

Tegaserod is a motility stimulant. Therapeutic effect is achieved through activation of 5-HT₄ receptors of the enteric nervous system in the gastrointestinal tract. Tegaserod stimulates gastrointestinal motility and the peristaltic reflex, and possibly also reduces abdominal pain (Rossi, 2004).

References

• Rossi, S (Ed.) (2004). Australian Medicines Handbook 2004 (AMH). Adelaide: Australian Medicines Handbook. ISBN 0-9578521-4-2.

Most likely you found this site by searching for elnorm, but it is probable that you were really looking for information on zelnorm instead. The goal of searchspell is to direct the 10 to 20% of all internet queries that contain variant spellings to the resources they were really looking for; in this case "zelnorm" resources. If you believe the information on this site is in error, please contact us at mistype@gmail.com to provide details of the misinformation.

If you are interested in adding to the content of this site, or if you are interested in supporting the efforts of misytped.info by placing your product information on all of the variant zelnorm pages, please contact mistype@gmail.com for details.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "zelnorm".